Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. <i>Toxins</i> 2022, <i>14</i>, 478
The authors wish to make corrections to their paper [...]
Main Authors: | Hossein Panjideh, Nicole Niesler, Alexander Weng, Hendrik Fuchs |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/14/10/703 |
Similar Items
-
Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861
by: Hossein Panjideh, et al.
Published: (2022-07-01) -
Magnetic Nanoparticle-Based Dianthin Targeting for Controlled Drug Release Using the Endosomal Escape Enhancer SO1861
by: Ajmal Zarinwall, et al.
Published: (2021-04-01) -
Glycosylated Triterpenoids as Endosomal Escape Enhancers in Targeted Tumor Therapies
by: Hendrik Fuchs, et al.
Published: (2017-03-01) -
Dianthin and Its Potential in Targeted Tumor Therapies
by: Hendrik Fuchs
Published: (2019-10-01) -
Augmenting the Efficacy of Immunotoxins and Other Targeted Protein Toxins by Endosomal Escape Enhancers
by: Hendrik Fuchs, et al.
Published: (2016-07-01)